ARCHIVES

Micafungin Bests Fluconazole In Phase III Antifungal Trial

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Clarifies Policy On Small, Short-Term Research Grants

July 5, 1996

Frank Torti Named FDA Deputy Commissioner, To Take Leave As Wake Forest Center Director.

April 11, 2008

DCPC Board Okays Concept For $10 Mil. Program to Promote Cancer Management In Rural Areas

May 25, 1990

Study: HPV Testing Can Predict Precancers For Nearly Two Decades Following Exam

August 31, 2012

Hawaii Gets CBCCP Award

August 12, 1977

Studies of Oncotype DX Test Presented at ASCO Symposium

January 31, 2014